Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Odyssey Health (ODYY) Income from Continuing Operations (2016 - 2026)

Odyssey Health has reported Income from Continuing Operations over the past 8 years, most recently at 2900591.0 for Q3 2021.

  • For Q3 2021, Income from Continuing Operations fell 117.76% year-over-year to 2900591.0; the TTM value through Jul 2021 reached 16933094.0, down 289.37%, while the annual FY2025 figure was 1273269.0, 52.1% up from the prior year.
  • Income from Continuing Operations for Q3 2021 was 2900591.0 at Odyssey Health, up from 12451690.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 31173.0 in Q1 2017 and troughed at 23410258.0 in Q3 2019.
  • A 5-year average of 2399475.42 and a median of 247241.0 in 2018 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 23570.87% in 2019 and later surged 94.31% in 2020.
  • Year by year, Income from Continuing Operations stood at 63408.0 in 2017, then dropped by 9.6% to 69496.0 in 2018, then tumbled by 1938.41% to 1416612.0 in 2019, then soared by 49.77% to 711514.0 in 2020, then crashed by 307.66% to 2900591.0 in 2021.
  • Business Quant data shows Income from Continuing Operations for ODYY at 2900591.0 in Q3 2021, 12451690.0 in Q2 2021, and 869299.0 in Q1 2021.